Jennifer S Steger, Indira Durai, Annamalai Odayappan, Ramalakshmi Raman, Talla Sruthi, Allisa J Song, George Puthuran, Rengaraj Venkatesh, Elizabeth Colantuoni, Alan L Robin
OBJECTIVE OR PURPOSE: Examine if 12.5 μL timolol maleate 0.5% microdrops dispensed with the Nanodropper® Adaptor provide non-inferior intraocular pressure (IOP) reduction compared to conventional, 28 μL drops in open-angle glaucoma (OAG) and ocular hypertension (OHT) patients. DESIGN: Prospective, non-inferiority, parallel, multicenter, single-masked, active-controlled, randomized trial. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: Treatment-naïve subjects that were recently diagnosed with OAG/OHT at the Aravind Eye Care System...
March 14, 2024: Ophthalmology